ArticleThe Permanente journal2025
A Hybrid Chart Review of Premature Coronary Artery Disease: An Opportunity to Improve Diagnostic Excellence and Management.
Article in The Permanente journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPremature coronary artery disease (premCAD) and its risk factors may not always be diagnosed or treated optimally.
objectiveThis study reviewed a sample of patients with premCAD within an integrated health care system to identify opportunities for improved diagnosis and care.
designRetrospective chart review.
participantsThe authors reviewed a sample of 28 patients with acute myocardial infarction before age 50. KEY
resultsSeveral opportunities were found, including lack of documentation of family history of premCAD (only present in 5/28 [18%]); delays or failure to diagnose in electronic chart problem in patients with diabetes mellitus (3/15 [20%]); failure to diagnose obesity in patients with a body mass index > 30 (12/28 [43%]); and gaps in continuity of care in patients who were new members (3/28 [11%]). These findings led to several changes, including improved identification and monitoring of patients with possible diabetes mellitus and obesity; improved identification of patients with increased risk of premCAD; and improved identification of premCAD risk factors in newly enrolled members.
conclusionsThis study highlights the value of a systematic approach to identifying variability and in developing tailored strategies to improve the diagnosis and management of premCAD and reduce future incidence. This approach can be used in other settings and conditions to identify areas for system improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.